Lexaria BioscienceLEXX
13F holders, Q1 2024 (March 31)25holders
1famous investor
$3.63avg. 13F price*
At the end of Q1 2024, 25 institutions reported holding Lexaria Bioscience Corp. (LEXX) in their 13F filings. The largest holders were Invenomic Capital Management LP ($1.7M), Geode Capital Management, LLC ($361K) and Vanguard Group Inc. ($309K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Lexaria Bioscience Corp.
- CUSIP
- 52886N406
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $624K |
| Exits | 5 | $402K |
Ownership 25 holders
| Invenomic Capital Management LP | 0.09% | Reduce -35.3% | 473,265 | $1.7M |
| Geode Capital Management, LLC | 0.00% | Add +85.4% | 99,338 | $361K |
| Vanguard Group Inc. | 0.00% | Add +84.2% | 85,156 | $309K |
| Raymond James Financial Services Advisors, Inc. | 0.00% | New | 39,550 | $144K |
| State Street Corp. | 0.00% | New | 39,301 | $143K |
| ADAR1 Capital Management, LLC | 0.03% | Add +1537.5% | 26,626 | $97K |
| Welch Group, LLC | 0.00% | New | 24,000 | $87K |
| Morgan Stanley | 0.00% | New | 23,354 | $85K |
| Northern Trust Corp. | 0.00% | New | 18,389 | $67K |
| Citadel Advisors | 0.00% | Reduce -46.4% | 15,856 | $58K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | New | 10,323 | $37K |
| XTX Topco Ltd | 0.01% | New | 10,276 | $37K |
| Royal Bank of Canada | 0.00% | Add +1748.5% | 7,283 | $26K |
| Oakworth Capital, Inc. | 0.00% | New | 5,000 | $18K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -53.5% | 2,702 | $10K |
| 1832 Asset Management L.P. | 0.00% | No change | 2,686 | $10K |
| Osaic Holdings, Inc. | 0.00% | Add +386.7% | 2,190 | $8K |
| BlackRock Inc. | 0.00% | New | 1,508 | $5K |
| Wells Fargo & Company | 0.00% | Add +1.0% | 1,073 | $4K |
| Aspire Private Capital, LLC | 0.00% | No change | 400 | $1K |
| Bank of America Corp. | 0.00% | New | 237 | $860 |
| Farther Finance Advisors, LLC | 0.00% | No change | 166 | $568 |
| Allworth Financial LP | 0.00% | No change | 89 | $324 |
| Toronto Dominion Bank | 0.00% | No change | 13 | $47 |
| Gables Capital Management Inc. | 0.00% | No change | 13 | $47 |
"% of holder's portfolio" is LEXX's weight in each manager's 13F, not the share of Lexaria Bioscience Corp. the manager owns.